Cargando…
A Pan-Cancer Analysis of SLC12A5 Reveals Its Correlations with Tumor Immunity
BACKGROUND: Solute carrier family 12 member 5 (SLC12A5) has been reported to play an oncogenic role in certain malignancies. Its prognostic roles and immune mechanisms of action in human cancers, however, remain largely unknown. METHODS: Data derived from TCGA, GEPIA, and TIMER databases were utiliz...
Autores principales: | Jiang, Yi, Liao, Hong-li, Chen, Li-ya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495467/ https://www.ncbi.nlm.nih.gov/pubmed/34630736 http://dx.doi.org/10.1155/2021/3062606 |
Ejemplares similares
-
Comprehensive Analysis and Validation of Solute Carrier Family 25 (SLC25) and Its Correlation with Immune Infiltration in Pan-Cancer
por: Liu, Ao-ran, et al.
Publicado: (2022) -
A pan-cancer analysis revealed the role of the SLC16 family in cancer
por: Li, Jun, et al.
Publicado: (2021) -
A Comprehensive Prognostic and Immune Analysis of SLC41A3 in Pan-Cancer
por: Liu, Jun, et al.
Publicado: (2021) -
A pan-cancer analysis of SLC1A5 in human cancers
por: Ni, Juan, et al.
Publicado: (2023) -
Targeting SLC1A5 and SLC3A2/SLC7A5 as a Potential Strategy to Strengthen Anti-Tumor Immunity in the Tumor Microenvironment
por: Nachef, Marianna, et al.
Publicado: (2021)